These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10809341)

  • 1. The effect of ritonavir on the pharmacokinetics of meperidine and normeperidine.
    Piscitelli SC; Kress DR; Bertz RJ; Pau A; Davey R
    Pharmacotherapy; 2000 May; 20(5):549-53. PubMed ID: 10809341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction between ritonavir and clarithromycin.
    Ouellet D; Hsu A; Granneman GR; Carlson G; Cavanaugh J; Guenther H; Leonard JM
    Clin Pharmacol Ther; 1998 Oct; 64(4):355-62. PubMed ID: 9797791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers.
    Penzak SR; Hon YY; Lawhorn WD; Shirley KL; Spratlin V; Jann MW
    J Clin Psychopharmacol; 2002 Aug; 22(4):366-70. PubMed ID: 12172335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers.
    Peytavin G; Gautran C; Otoul C; Cremieux AC; Moulaert B; Delatour F; Melac M; Strolin-Benedetti M; Farinotti R
    Eur J Clin Pharmacol; 2005 Jun; 61(4):267-73. PubMed ID: 15889300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
    van Heeswijk RP; Veldkamp AI; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
    AIDS; 2000 Jun; 14(9):F103-10. PubMed ID: 10894270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir.
    Gutierrez MM; Rosenberg J; Abramowitz W
    Clin Ther; 2003 Apr; 25(4):1200-10. PubMed ID: 12809966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of meperidine and its metabolite normeperidine in hemodialysis patients with chronic noncancer pain.
    Hsu CH; Lin TC; Lu CC; Lin SH; Ho ST
    J Pain Symptom Manage; 2014 Apr; 47(4):801-5. PubMed ID: 23870842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir.
    Hsu A; Granneman GR; Cao G; Carothers L; el-Shourbagy T; Baroldi P; Erdman K; Brown F; Sun E; Leonard JM
    Clin Pharmacol Ther; 1998 Apr; 63(4):453-64. PubMed ID: 9585800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.
    Schmitt C; Kaeser B; Riek M; Bech N; Kreuzer C
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):192-9. PubMed ID: 20197013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bioequivalence study comparing two formulations of lopinavir/ritonavir capsules.
    Tippabhotla SK; Thudi NR; Raghuvanshi R; Khuroo AH; Gurule S; Mishra S; Monif T; Lao VK
    Int J Clin Pharmacol Ther; 2008 Apr; 46(4):204-10. PubMed ID: 18397695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients.
    Waters LJ; Moyle G; Bonora S; D'Avolio A; Else L; Mandalia S; Pozniak A; Nelson M; Gazzard B; Back D; Boffito M
    Antivir Ther; 2007; 12(5):825-30. PubMed ID: 17713166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses.
    Hamamoto-Hardman BD; Steffey EP; McKemie DS; Kass PH; Knych HK
    BMC Vet Res; 2020 Oct; 16(1):368. PubMed ID: 32998730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors.
    Washington CB; Flexner C; Sheiner LB; Rosenkranz SL; Segal Y; Aberg JA; Blaschke TF;
    Clin Pharmacol Ther; 2003 May; 73(5):406-16. PubMed ID: 12732841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meperidine-induced QTc-interval prolongation: prevalence, risk factors, and correlation to plasma drug and metabolite concentrations
.
    Keller GA; Villa Etchegoyen MC; Fernández N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):275-285. PubMed ID: 27509828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers.
    Schöller-Gyüre M; Kakuda TN; Sekar V; Woodfall B; De Smedt G; Lefebvre E; Peeters M; Hoetelmans RM
    Antivir Ther; 2007; 12(5):789-96. PubMed ID: 17713162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of saquinavir-ritonavir on cytochrome P450 3A4 activity in healthy volunteers using midazolam as a probe.
    Schmitt C; Hofmann C; Riek M; Patel A; Zwanziger E
    Pharmacotherapy; 2009 Oct; 29(10):1175-81. PubMed ID: 19792991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects.
    Zhu L; Persson A; Mahnke L; Eley T; Li T; Xu X; Agarwala S; Dragone J; Bertz R
    J Clin Pharmacol; 2011 Mar; 51(3):368-77. PubMed ID: 20457590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluoxetine on pharmacokinetics of ritonavir.
    Ouellet D; Hsu A; Qian J; Lamm JE; Cavanaugh JH; Leonard JM; Granneman GR
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3107-12. PubMed ID: 9835499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus.
    Khaliq Y; Gallicano K; Venance S; Kravcik S; Cameron DW
    Clin Pharmacol Ther; 2000 Dec; 68(6):637-46. PubMed ID: 11180024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.
    Aarnoutse RE; Grintjes KJ; Telgt DS; Stek M; Hugen PW; Reiss P; Koopmans PP; Hekster YA; Burger DM
    Clin Pharmacol Ther; 2002 Jan; 71(1):57-67. PubMed ID: 11823758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.